2026-04-13T01:52:54Zhttps://recercat.cat/oai/request

oai:recercat.cat:20.500.12328/45522025-05-16T12:55:49Zcom_2072_67741col_2072_484352

00925njm 22002777a 4500 dc Barco, Israel author Chabrera, Carolina author García Fernández, Antonio author Fraile, Manel author Vidal, Carmen author Mitru, Claudia Beatriz author Porta, Oriol author García-Font, Marc author 2023 Background: Breast Cancer (BC) remains the most diagnosed malignancy and the most common cause of cancer-related mortality in women worldwide. Covid-19 mortality in BC patients has been linked to comorbid conditions rather than to cancer treatment itself, although this was not confirmed by a meta-analysis. Also, during Covid-19 outbreaks, a great deal of health care resources is reassigned to critical Covid-19 patients. Patients and Methods: During 5 consecutive trimesters (from 1/12/2020 to 31/3/2021) 2511 BC patients older than 20 years from our institution were surveyed. 1043 of them had received a Covid test and these made our study group, which was conveniently compared with the Covid-19 tested background feminine Catalan population. Results: 13.1% of our patients presented with a positive Covid-19 test, whereas confirmed COVID-19 infection amounted to 7.1% of the feminine Catalan tested population. The COVID-19-specific mortality rate was 11.7% (16/137) in the study group, which compares with a 4.7% rate for the overall population. Most deaths occurred in patients over 70. Conclusion: Three clinical factors were significantly associated with Covid-19 mortality in BC, namely lack of hormone therapy, distant metastases, and BC dwelling in nursing homes. BC patients are at a higher risk of Covid-19 infection and mortality in comparison with the reference group without BC. Barco, Israel; Chabrera, Carolina; García Fernández, Antonio [et al.]. COVID-19 incidence and mortality in patients operated on for breast cancer. Comparison with the general population. Clinical Breast Cancer, 2023, 23(2), p. 135-142. Disponible en: <https://www.sciencedirect.com/science/article/pii/S1526820922002476?via%3Dihub>. Fecha de acceso: 17 ene. 2025. DOI: 10.1016/j.clbc.2022.11.002 1526-8209 http://hdl.handle.net/20.500.12328/4552 https://dx.doi.org/10.1016/j.clbc.2022.11.002 Neoplàsies de mama Comorbilitat COVID-19 Residències d'avis Supervivència Neoplasias de mama Comorbilidad COVID-19 Residencias de ancianos Supervivencia Breast neoplasms Comorbidity COVID-19 Nursing homes Survival COVID-19 incidence and mortality in patients operated on for breast cancer. Comparison with the general population